VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 77 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $209,941 | -71.5% | 18,335 | -80.8% | 0.00% | -75.0% |
| Q1 2023 | $737,531 | +249.5% | 95,659 | +168.0% | 0.00% | +300.0% |
| Q3 2022 | $211,000 | -43.0% | 35,693 | -42.9% | 0.00% | -50.0% |
| Q2 2022 | $370,000 | -77.3% | 62,544 | -70.8% | 0.00% | -85.7% |
| Q1 2022 | $1,632,000 | +2814.3% | 214,184 | +943.6% | 0.01% | +1300.0% |
| Q4 2021 | $56,000 | -53.7% | 20,523 | -20.1% | 0.00% | -50.0% |
| Q1 2021 | $121,000 | -45.2% | 25,674 | +46.4% | 0.00% | -50.0% |
| Q2 2020 | $221,000 | -43.2% | 17,531 | -58.7% | 0.00% | -63.6% |
| Q1 2020 | $389,000 | -57.1% | 42,463 | -34.6% | 0.01% | -35.3% |
| Q4 2019 | $906,000 | +2.5% | 64,932 | +26.4% | 0.02% | -5.6% |
| Q3 2019 | $884,000 | +112.5% | 51,370 | +16.0% | 0.02% | -10.0% |
| Q4 2018 | $416,000 | +35.9% | 44,289 | +183.0% | 0.02% | +33.3% |
| Q2 2018 | $306,000 | -10.8% | 15,650 | -14.2% | 0.02% | -25.0% |
| Q1 2018 | $343,000 | – | 18,239 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |